Effect of blue light stimulation of the optic nerve head on choroidal thickness and axial length in children with myopia

Not Applicable

Recruiting

• Conditions: Myopia; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12623000928617
• Lead Sponsor: Dopavision GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-29
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Male or female volunteers aged between 6 and 16 years.
Documented diagnosis of myopia as characterized by spherical equivalent refraction ranging from -0.5 to -6.0 D inclusive.
Corrected visual acuity of at least 0.2 logMAR in each eye.
Good tolerability of test session with the VR system.
Binocular adequacy as tested with VR.
Ability to understand and give assent.

Exclusion Criteria

Not habitually corrected for myopia.
Concomitant therapies for control of myopia progression.
Former myopia interventions within the following washout periods:
- Low-dose atropine eyedrops within the last 3 months.
- Orthokeratology contact lenses within the last 3 months.
Eye diseases/conditions such as
- Anisometropia of at least 1.5 D
- Astigmatism of at least 3 D
- Ophthalmological comorbidities
- Optic nerve abnormalities
- Suspicion of syndromic or monogenetic myopia
Systemic illnesses affecting eye health.
Any illnesses affecting dopamine function (such as sleep disorder, ADHD, Parkinson’s Disease, and autism spectrum disorders).
Medication affecting dopamine function, accommodation, pupil size, or having an impact on the ocular surface (topical ocular medications).
Participation in other clinical studies.
Medical history (or family history) of photosensitive epilepsy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified